Karuna Therapeutics Price Prediction

KRTXDelisted Stock  USD 203.11  1.46  0.71%   
At this time, the value of RSI of Karuna Therapeutics' share price is approaching 34. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Karuna Therapeutics, making its price go up or down.

Oversold Vs Overbought

34

 
Oversold
 
Overbought
The successful prediction of Karuna Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Karuna Therapeutics, which may create opportunities for some arbitrage if properly timed.
Using Karuna Therapeutics hype-based prediction, you can estimate the value of Karuna Therapeutics from the perspective of Karuna Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Karuna Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Karuna because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Karuna Therapeutics after-hype prediction price

    
  USD 203.11  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Karuna Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
178.16178.16223.42
Details
Naive
Forecast
LowNextHigh
211.65211.65211.65
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
202.09203.92205.75
Details

Karuna Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Karuna Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Karuna Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Karuna Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Karuna Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Karuna Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Karuna Therapeutics' historical news coverage. Karuna Therapeutics' after-hype downside and upside margins for the prediction period are 203.11 and 203.11, respectively. We have considered Karuna Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
203.11
203.11
Downside
203.11
After-hype Price
203.11
Upside
Karuna Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Karuna Therapeutics is based on 3 months time horizon.

Karuna Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Karuna Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Karuna Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Karuna Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
12 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
203.11
203.11
0.00 
0.00  
Notes

Karuna Therapeutics Hype Timeline

Karuna Therapeutics is now traded for 203.11. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Karuna is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Karuna Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 203.11. About 86.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.46. Karuna Therapeutics recorded a loss per share of 11.74. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be uncertain.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Karuna Therapeutics Related Hype Analysis

Having access to credible news sources related to Karuna Therapeutics' direct competition is more important than ever and may enhance your ability to predict Karuna Therapeutics' future price movements. Getting to know how Karuna Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Karuna Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ISEEIVERIC Bio(0.03)10 per month 0.25  0.22  2.45 (1.52) 18.29 
BPMCBlueprint Medicines Corp(1.72)8 per month 2.61 (0.03) 4.90 (3.62) 14.28 
AMLXAmylyx Pharmaceuticals 0.02 11 per month 4.02  0.24  10.06 (6.13) 33.56 
DAWNDay One Biopharmaceuticals 0.23 9 per month 2.72 (0.04) 3.84 (3.69) 11.44 
XFORX4 Pharmaceuticals 0.02 7 per month 0.00 (0.08) 6.90 (10.61) 62.35 
INZYInozyme Pharma(0.03)8 per month 0.00 (0.27) 5.68 (7.92) 16.62 
ABOSAcumen Pharmaceuticals(0.10)4 per month 0.00 (0.06) 7.52 (6.67) 28.07 
MREOMereo BioPharma Group(0.15)9 per month 0.00 (0.10) 5.14 (5.79) 19.32 
TERNTerns Pharmaceuticals 0.30 8 per month 0.00 (0.09) 5.68 (5.96) 34.09 
MRTXMirati Ther 0.00 0 per month 0.00 (0.18) 4.02 (4.07) 16.13 
APLSApellis Pharmaceuticals(1.10)9 per month 0.00 (0.13) 4.31 (5.17) 15.97 
CYTKCytokinetics 1.67 12 per month 0.00 (0.12) 3.42 (4.15) 14.08 
DICEDice Molecules Holdings 0.02 7 per month 1.14  0.10  5.66 (2.91) 37.64 
EWTXEdgewise Therapeutics 0.32 10 per month 2.85  0.11  6.65 (4.70) 61.02 
DYNDyne Therapeutics 1.29 11 per month 0.00 (0.12) 5.70 (5.63) 32.99 

Karuna Therapeutics Additional Predictive Modules

Most predictive techniques to examine Karuna price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Karuna using various technical indicators. When you analyze Karuna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Karuna Therapeutics Predictive Indicators

The successful prediction of Karuna Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Karuna Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Karuna Therapeutics based on analysis of Karuna Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Karuna Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Karuna Therapeutics's related companies.

Story Coverage note for Karuna Therapeutics

The number of cover stories for Karuna Therapeutics depends on current market conditions and Karuna Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Karuna Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Karuna Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Karuna Therapeutics Short Properties

Karuna Therapeutics' future price predictability will typically decrease when Karuna Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Karuna Therapeutics often depends not only on the future outlook of the potential Karuna Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Karuna Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding37 M
Cash And Short Term Investments1.3 B
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Karuna Stock

If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios